ATE173271T1 - Sterin epoxid verbindungen zur krebsbehandlung - Google Patents

Sterin epoxid verbindungen zur krebsbehandlung

Info

Publication number
ATE173271T1
ATE173271T1 AT95902957T AT95902957T ATE173271T1 AT E173271 T1 ATE173271 T1 AT E173271T1 AT 95902957 T AT95902957 T AT 95902957T AT 95902957 T AT95902957 T AT 95902957T AT E173271 T1 ATE173271 T1 AT E173271T1
Authority
AT
Austria
Prior art keywords
group
carbon atoms
hydroxyl group
sterol
cancer treatment
Prior art date
Application number
AT95902957T
Other languages
English (en)
Inventor
Chihiro Yokoo
Hisaya Wada
Hidemichi Mitome
Tatsuhiko Sano
Katsuo Hatayama
Yasuji Yamada
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE173271T1 publication Critical patent/ATE173271T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95902957T 1993-12-15 1994-12-14 Sterin epoxid verbindungen zur krebsbehandlung ATE173271T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31524693 1993-12-15

Publications (1)

Publication Number Publication Date
ATE173271T1 true ATE173271T1 (de) 1998-11-15

Family

ID=18063133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95902957T ATE173271T1 (de) 1993-12-15 1994-12-14 Sterin epoxid verbindungen zur krebsbehandlung

Country Status (9)

Country Link
US (1) US5712263A (de)
EP (1) EP0735047B1 (de)
AT (1) ATE173271T1 (de)
AU (1) AU679302B2 (de)
CA (1) CA2178900A1 (de)
DE (1) DE69414602T2 (de)
DK (1) DK0735047T3 (de)
ES (1) ES2124995T3 (de)
WO (1) WO1995016699A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP1945240B1 (de) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Zusammensetzungen mit rezeptor-assoziierten protein (rap) varianten, die für cr-haltige proteine spezifisch sind und ihre verwendungen
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122521A (en) * 1990-07-17 1992-06-16 Taisho Pharmaceutical Co., Ltd. Sterol compound

Also Published As

Publication number Publication date
AU1200395A (en) 1995-07-03
DK0735047T3 (da) 1999-07-26
AU679302B2 (en) 1997-06-26
DE69414602T2 (de) 1999-04-08
EP0735047B1 (de) 1998-11-11
DE69414602D1 (de) 1998-12-17
WO1995016699A1 (en) 1995-06-22
ES2124995T3 (es) 1999-02-16
EP0735047A1 (de) 1996-10-02
CA2178900A1 (en) 1995-06-22
EP0735047A4 (de) 1996-11-27
US5712263A (en) 1998-01-27

Similar Documents

Publication Publication Date Title
FI940788A0 (fi) Alkoholi- tai aldehydijohdannaiset ja niiden käyttö
ATE173271T1 (de) Sterin epoxid verbindungen zur krebsbehandlung
ZA896685B (en) Substituted beta-diketones
BR9507355A (pt) Derivodos de 22-tiavitamina D3
ATE131061T1 (de) Förderung der osteogenese durch verwendung von vitamin d-derivaten.
DE69800922D1 (de) Verfahren zur Herstellung von 2-Cyanobiphenyl Verbindungen
GR3018629T3 (en) Piperidine compounds with glycosidase inhibition activity.
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
GB2095673B (en) Polymethylene-morpholines
AU4834293A (en) Novel 7-substituted oxa- or azasteroid compound
GB8624686D0 (en) Preparing penems
MX9303490A (es) Proceso para preaparar (1'r.3s 4r) 4-aciltio-azetidinonas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee